438 related articles for article (PubMed ID: 9166757)
1. Preferential potentiation of the effects of serotonin uptake inhibitors by 5-HT1A receptor antagonists in the dorsal raphe pathway: role of somatodendritic autoreceptors.
Romero L; Artigas F
J Neurochem; 1997 Jun; 68(6):2593-603. PubMed ID: 9166757
[TBL] [Abstract][Full Text] [Related]
2. In vivo control of 5-hydroxytryptamine release by terminal autoreceptors in rat brain areas differentially innervated by the dorsal and median raphe nuclei.
Hervás I; Bel N; Fernández AG; Palacios JM; Artigas F
Naunyn Schmiedebergs Arch Pharmacol; 1998 Sep; 358(3):315-22. PubMed ID: 9774218
[TBL] [Abstract][Full Text] [Related]
3. Somatodendritic action of pindolol to attenuate the paroxetine-induced decrease in serotonin release from the rat ventral hippocampus: a microdialysis study.
Míguez JM; Paz-Valiñas L; Míguez I; Aldegunde M
Naunyn Schmiedebergs Arch Pharmacol; 2002 May; 365(5):378-87. PubMed ID: 12012024
[TBL] [Abstract][Full Text] [Related]
4. Raphe 5-HT1A autoreceptors, but not postsynaptic 5-HT1A receptors or beta-adrenoceptors, restrain the citalopram-induced increase in extracellular 5-hydroxytryptamine in vivo.
Hjorth S; Bengtsson HJ; Milano S
Eur J Pharmacol; 1996 Nov; 316(1):43-7. PubMed ID: 8982649
[TBL] [Abstract][Full Text] [Related]
5. Effect of fluoxetine on extracellular 5-hydroxytryptamine in rat brain. Role of 5-HT autoreceptors.
Hervás I; Artigas F
Eur J Pharmacol; 1998 Sep; 358(1):9-18. PubMed ID: 9809863
[TBL] [Abstract][Full Text] [Related]
6. Effect of chronic administration of the selective serotonin (5-HT) uptake inhibitor citalopram on extracellular 5-HT and apparent autoreceptor sensitivity in rat forebrain in vivo.
Auerbach SB; Hjorth S
Naunyn Schmiedebergs Arch Pharmacol; 1995 Dec; 352(6):597-606. PubMed ID: 9053730
[TBL] [Abstract][Full Text] [Related]
7. Effect of a selective 5-HT reuptake inhibitor in combination with 5-HT1A and 5-HT1B receptor antagonists on extracellular 5-HT in rat frontal cortex in vivo.
Sharp T; Umbers V; Gartside SE
Br J Pharmacol; 1997 Jul; 121(5):941-6. PubMed ID: 9222551
[TBL] [Abstract][Full Text] [Related]
8. Further evidence for the importance of 5-HT1A autoreceptors in the action of selective serotonin reuptake inhibitors.
Hjorth S; Auerbach SB
Eur J Pharmacol; 1994 Aug; 260(2-3):251-5. PubMed ID: 7988652
[TBL] [Abstract][Full Text] [Related]
9. Blockade of substance P (neurokinin 1) receptors enhances extracellular serotonin when combined with a selective serotonin reuptake inhibitor: an in vivo microdialysis study in mice.
Guiard BP; Przybylski C; Guilloux JP; Seif I; Froger N; De Felipe C; Hunt SP; Lanfumey L; Gardier AM
J Neurochem; 2004 Apr; 89(1):54-63. PubMed ID: 15030389
[TBL] [Abstract][Full Text] [Related]
10. Difference in the in vivo influence of serotonin1A autoreceptors on serotonin release in prefrontal cortex and dorsal hippocampus of the same rat treated with fluoxetine.
Li XM; Perry KW; Wong DT
Chin J Physiol; 1999 Jun; 42(2):53-9. PubMed ID: 10513599
[TBL] [Abstract][Full Text] [Related]
11. Do 5-HT1B/1D autoreceptors modulate dorsal raphe cell firing? In vivo electrophysiological studies in guinea pigs with GR127935.
Sprouse J; Reynolds L; Rollema H
Neuropharmacology; 1997; 36(4-5):559-67. PubMed ID: 9225281
[TBL] [Abstract][Full Text] [Related]
12. Blockade of 5-HT1A receptors by (+/-)-pindolol potentiates cortical 5-HT outflow, but not antidepressant-like activity of paroxetine: microdialysis and behavioral approaches in 5-HT1A receptor knockout mice.
Guilloux JP; David DJ; Guiard BP; Chenu F; Repérant C; Toth M; Bourin M; Gardier AM
Neuropsychopharmacology; 2006 Oct; 31(10):2162-72. PubMed ID: 16452992
[TBL] [Abstract][Full Text] [Related]
13. Effect of 5-HT1A receptor antagonists on citalopram-induced increase in extracellular serotonin in the frontal cortex, striatum and dorsal hippocampus.
Invernizzi R; Velasco C; Bramante M; Longo A; Samanin R
Neuropharmacology; 1997; 36(4-5):467-73. PubMed ID: 9225271
[TBL] [Abstract][Full Text] [Related]
14. Effects of sustained administration of the serotonin and norepinephrine reuptake inhibitor venlafaxine: I. in vivo electrophysiological studies in the rat.
Béïque J; de Montigny C; Blier P; Debonnel G
Neuropharmacology; 2000 Jul; 39(10):1800-12. PubMed ID: 10884561
[TBL] [Abstract][Full Text] [Related]
15. The 5-HT1A receptor antagonist (S)-UH-301 augments the increase in extracellular concentrations of 5-HT in the frontal cortex produced by both acute and chronic treatment with citalopram.
Arborelius L; Nomikos GG; Hertel P; Salmi P; Grillner P; Höök BB; Hacksell U; Svensson TH
Naunyn Schmiedebergs Arch Pharmacol; 1996 May; 353(6):630-40. PubMed ID: 8738296
[TBL] [Abstract][Full Text] [Related]
16. N-methyl-d-aspartate receptors regulate 5-HT release in the raphe nuclei and frontal cortex of freely moving rats: differential role of 5-HT1A autoreceptors.
Pallotta M; Segieth J; Whitton PS
Brain Res; 1998 Feb; 783(2):173-8. PubMed ID: 9507110
[TBL] [Abstract][Full Text] [Related]
17. Effect of chronic paroxetine treatment on 5-HT1B and 5-HT1D autoreceptors in rat dorsal raphe nucleus.
Davidson C; Stamford JA
Neurochem Int; 2000 Feb; 36(2):91-6. PubMed ID: 10676872
[TBL] [Abstract][Full Text] [Related]
18. [Effects of (+/-)-pindolol over increased extracellular 5-HT level induced by fluvoxamine: regional difference in effect among the raphe, dorsal hippocampus and prefrontal cortex as measured by in vivo microdialysis technique].
Nakada S
Nihon Shinkei Seishin Yakurigaku Zasshi; 2000 May; 20(2):51-60. PubMed ID: 11062862
[TBL] [Abstract][Full Text] [Related]
19. Differential effect of local infusion of serotonin reuptake inhibitors in the raphe versus forebrain and the role of depolarization-induced release in increased extracellular serotonin.
Tao R; Ma Z; Auerbach SB
J Pharmacol Exp Ther; 2000 Aug; 294(2):571-9. PubMed ID: 10900234
[TBL] [Abstract][Full Text] [Related]
20. Autoreceptor antagonists enhance the effect of the reuptake inhibitor citalopram on extracellular 5-HT: this effect persists after repeated citalopram treatment.
Gundlah C; Hjorth S; Auerbach SB
Neuropharmacology; 1997; 36(4-5):475-82. PubMed ID: 9225272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
